PYC.L
Physiomics Plc provides consulting services to pharmaceutical companies in the areas of outsourced quantitative pharmacology and computational biology in the United Kingdom, the United States, and the European Union. It offers modeling, simulation, and data analysis services covering various ranges of oncology research and development using its proprietary Virtual Tumour predictive software. The company also develops technology for use in the field of personalized medicine. Physiomics Plc was incorporated in 2001 and is based in Oxford, the United Kingdom.
Industry
Biotechnology
IPO Date
2004-12-20
Stock Exchange
LSE
Ticker
PYC.L
According to Physiomics Plc’s latest financial reports and current stock price. The company's current PE Ratio is -0.29. This represents a change of -74.86% compared to the average of -1.15 of the last 4 quarters.
The mean historical PE Ratio of Physiomics Plc over the last ten years is -16.50. The current -0.29 PE Ratio has changed 75.72% with respect to the historical average. Over the past ten years (40 quarters), PYC.L's PE Ratio was at its highest in in the June 2020 quarter at 94.50. The PE Ratio was at its lowest in in the December 2020 quarter at -24.40.
Average
-16.50
Median
-7.29
Minimum
-79.53
Maximum
-1.35
Discovering the peaks and valleys of Physiomics Plc PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 905.66%
Maximum Annual PE Ratio = -1.35
Minimum Annual Increase = -82.46%
Minimum Annual PE Ratio = -79.53
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -2.67 | 33.94% |
| 2023 | -1.99 | -82.46% |
| 2022 | -11.35 | -60.60% |
| 2021 | -28.80 | -63.79% |
| 2020 | -79.53 | 296.78% |
| 2019 | -20.04 | 48.06% |
| 2018 | -13.54 | 905.66% |
| 2017 | -1.35 | -46.97% |
| 2016 | -2.54 | -21.54% |
| 2015 | -3.24 | -53.27% |
The current PE Ratio of Physiomics Plc (PYC.L) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.33
5-year avg
-24.87
10-year avg
-16.50
Physiomics Plc’s PE Ratio is less than ValiRx plc (-0.22), less than Trellus Health plc (-0.17), greater than Polarean Imaging plc (-0.37), greater than Roquefort Therapeutics plc (-1.80), greater than Theracryf Plc (-0.69),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.22 | N/A | |
| -0.17 | N/A | |
| -0.37 | N/A | |
| -1.80 | N/A | |
| -0.69 | N/A |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Physiomics Plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Physiomics Plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Physiomics Plc's PE Ratio?
How is the PE Ratio calculated for Physiomics Plc (PYC.L)?
What is the highest PE Ratio for Physiomics Plc (PYC.L)?
What is the 3-year average PE Ratio for Physiomics Plc (PYC.L)?
What is the 5-year average PE Ratio for Physiomics Plc (PYC.L)?
How does the current PE Ratio for Physiomics Plc (PYC.L) compare to its historical average?